PMI’s smoke-free product assessment approach

      Our scientific assessment is built on a collaborative approach and expertise in the fields of chemistry, biology, informatics, and medicine. Our practices are inspired by the pharmaceutical industry and are aligned to the draft guidance issued by the U.S. Food and Drug Administration’s Center for Tobacco Products in 2012. This is a brief overview of our assessment program.

      Assessment approach

      Platform Development

      What is the scientific basis of the development of our smoke-free products?

      platform assessment approach
      Assessment approach

      Toxicological assessment

      We assess our smoke-free products in vitro and in vivo to verify their potential to reduce individual health risk compared with continued smoking.

      Assessment Approach

      Clinical assessment

      Our clinical studies provide information on how the body responds when smokers switch to our smoke-free products, and how this differs from continued smoking or quitting for the duration of these studies.

      clinical assessment
      perception and behavior assesment
      Assessment approach

      Perception and behavior assessment

      We assess the impact of potential communication on adult consumers, and how this might influence their risk perception and usage of our smoke-free products.

      Assessment Approach

      Long-term assessment

      Our program monitors events linked to the usage of our smoke-free products and also studies the effects of switching.

      long-term assessment